Month: January 2025

Study Supported by $2.6 Million FDA Orphan Products Development Grant PRINCETON, N.J., Jan. 14, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases […]

Vancouver, British Columbia–(Newsfile Corp. – January 8, 2025) – Midnight Sun Mining Corporation (TSXV: MMA) (OTC Pink: MDNGF) (“Midnight Sun” or the “Company”) is pleased to announce the completion of the previously announced exploration program […]